ENDOMIMETICS LLC
Birmingham, AL · Medtech · Private
Nitric oxide and antibiotic-loaded liposomal coating for knee implants to prevent post-operative infection, inflammation, and arthrofibrosis
endomimetics.com →- Grants
- $9.0M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Bionanomatrix coating for brain aneurysm coils to enhance healing | $553,378 | |
| Federal grant | Department of Health and Human Services · Phase I · Nitric oxide releasing nanomatrix wrap to enhance dialysis fistula maturation | $429,486 | |
| Federal grant | Department of Health and Human Services · Phase II · Nitric oxide releasing nanomatrix to enhance dialysis fistula maturation | $972,781 | |
| Federal grant | Department of Health and Human Services · Phase I · Coating to enhance endothelialization after left atrial appendage closure | $463,188 | |
| Federal grant | Department of Health and Human Services · Phase II · Nitric oxide releasing nanomatrix to enhance dialysis fistula maturation | $940,410 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | $563,196 | |
| Federal grant | Department of Health and Human Services · Phase II · Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | $940,759 | |
| Federal grant | Department of Health and Human Services · Phase I · Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. | $497,306 | |
| Federal grant | Department of Health and Human Services · Phase II · Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | $977,762 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants | $292,643 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants | $292,643 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | $920,119 | |
| Federal grant | Department of Health and Human Services · Phase I · Atherosclerosis assay development for drug efficacy and cytotoxicity screening | $304,119 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | $853,282 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1954 | Theranos Inc | — | $627M |
| 1955 | NOVAFLUX, INC. | — | — |
| 1956 | Artisight, Inc. | — | — |
| 1957 | ENDOMIMETICS LLC | — | — |
| 1958 | SPINEX, INC. | — | — |
| 1959 | ALLAY THERAPEUTICS INC | — | — |
| 1960 | LO BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptide Amphiphiles With Modified Degrading Sequences And Methods Of Use Thereofapplication
- Peptide Amphiphile Compositions And Methods Of Use Thereofapplication
- Peptide Amphiphile Compositions And Methods Of Use Thereofapplication
- Peptide Amphiphiles With Modified Degrading Sequences And Methods Of Use Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.